Gold nanoparticles meet medical radionuclides

Area of Science:

• Nanomedicine
• Nuclear Medicine
• Radiochemistry

Background:

• Gold nanoparticles possess unique optical and physicochemical properties beneficial for cancer diagnostics and therapeutics.
• Their capacity to carry radionuclides expands their application in nuclear medicine imaging and therapy.

Purpose of the Study:

• To review the radiolabeling of gold nanoparticles for nuclear medicine applications.
• To discuss the use of radiolabeled gold nanoparticles in multimodal imaging and targeted radionuclide therapy.
• To explore their role in enhancing cancer detection, therapy, and image-guided interventions.

Main Methods:

• Review of radiolabeling techniques for gold nanoparticles.
• Analysis of in vitro and in vivo studies in cancer models.
• Inclusion of Monte Carlo simulations for dose deposition analysis.

Main Results:

• Radiolabeled gold nanoparticles facilitate SPECT and PET imaging, providing insights into biodistribution and retention in tumors.
• These nanoparticles enhance targeted radionuclide therapy and nanobrachytherapy through increased dose deposition and radiosensitization.
• Demonstrated potential for image-guided therapy and improved treatment efficacy in various cancer models.

Conclusions:

• Radiolabeled gold nanoparticles are promising agents for multimodal cancer imaging and therapy.
• Their application in nuclear medicine offers enhanced diagnostic capabilities and therapeutic outcomes.
• Further research validates their role in improving radiation dose delivery and radiosensitization for cancer treatment.